大语言模型心血管年龄预测在急性冠脉综合征预后中的价值
本研究为回顾性队列研究,纳入47 249例接受经皮冠状动脉介入治疗的急性冠脉综合征患者,通过大语言模型预测心血管年龄并计算与实际年龄的差值Age-Gap。高Age-Gap组(≥8岁)较低Age-Gap组(<8岁)的MACCE发生率更高。校正混杂因素后,高Age-Gap组发生MACCE、心原性死亡、心肌梗死、卒中及全因死亡的风险均显著升高。
要点
- 大语言模型预测心血管年龄在ACS患者中可行,心血管年龄与实际年龄呈正相关。
- Age-Gap≥8岁与MACCE及全因死亡风险显著相关。
- Age-Gap与MACCE、心原性死亡及全因死亡风险存在非线性关系。
核心结论
- 采用大语言模型预测急性冠脉综合征患者的心血管年龄技术可行。
- 心血管年龄与实际年龄的差值Age-Gap与ACS患者的MACCE及全因死亡风险显著相关。
- 大语言模型预测的心血管年龄为ACS患者个体化风险评估提供了新的视角。
研究设计与样本
- 本研究为回顾性队列研究,纳入2015年11月至2023年5月于解放军北部战区总医院心血管内科住院并接受经皮冠状动脉介入治疗的急性冠脉综合征患者47 249例。
- 通过北部战区总医院心血管急危重症智能大模型结合患者的人口学特征、既往病史及实验室检验数据预测心血管年龄。
- 计算心血管年龄与实际年龄的差值Age-Gap,将患者分为高Age-Gap组(Age-Gap≥8岁)和低Age-Gap组(Age-Gap<8岁)。
- 主要终点为主要不良心脑血管事件,包括心原性死亡、心肌梗死、卒中和靶血管血运重建。
- 次要终点为MACCE的各个组分及全因死亡。
主要发现
- 患者的实际年龄为(61.1±10.4)岁,心血管年龄为(69.5±10.8)岁。
- 高Age-Gap组31 775例,低Age-Gap组15 474例。
- 心血管年龄与实际年龄呈正相关(r=0.87,P<0.000 1)。
- 随访时间为39.6(24.0,59.6)个月。
- 高Age-Gap组患者的MACCE发生率高于低Age-Gap组,分别为12.99%(4 127/31 775)和7.86%(1 216/15 474),P<0.000 1。
关键数值与推荐
- 校正年龄、性别、吸烟等因素后,与低Age-Gap患者相比,高Age-Gap患者发生MACCE风险更高(HR=1.47,95%CI 1.37~1.58,P<0.000 1)。
- 高Age-Gap组患者心原性死亡风险显著升高(HR=2.72,95%CI 2.36~3.15,P<0.000 1)。
- 高Age-Gap组患者心肌梗死风险显著升高(HR=1.77,95%CI 1.46~2.14,P<0.000 1)。
- 高Age-Gap组患者卒中风险显著升高(HR=1.24,95%CI 1.05~1.46,P=0.010 9)。
- 高Age-Gap组患者全因死亡风险显著升高(HR=2.01,95%CI 1.81~2.23,P<0.000 1)。
临床怎么用
- Age-Gap与MACCE、心原性死亡及全因死亡风险存在非线性关系,随着Age-Gap增加患者发生上述事件的风险明显升高。
- 大语言模型预测心血管年龄可用于急性冠脉综合征患者的个体化风险评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the application value of cardiovascular age prediction based on large language model for prognostic assessment in patients with acute coronary syndrome (ACS). Methods: This retrospective cohort study included 47 249 ACS patients who were admitted to the Department of Cardiology at the General Hospital of Northern Theater Command and underwent percutaneous coronary intervention between November 2015 and May 2023. Cardiovascular age was predicted using a large language model for cardiovascular critical care developed by our institution, incorporating patients' demographic characteristics, medical history, and laboratory data. The difference between cardiovascular age and chronological age was calculated as the Age-Gap. Based on previous studies, patients were categorized into the high Age-Gap group (Age-Gap≥8 years) and the low Age-Gap group (Age-Gap<8 years). The primary endpoint was major adverse cardiovascular and cerebrovascular events (MACCE), including cardiac death, myocardial infarction, stroke, and target vessel revascularization. Secondary endpoints included the individual components of MACCE and all-cause mortality. Pearson correlation analysis was used to assess the correlation between cardiovascular age and chronological age. Cox proportional hazards models were used to evaluate the association between Age-Gap and clinical outcomes, and restricted cubic spline analyses were applied to explore potential nonlinear relationships between Age-Gap and study endpoints. Results: The chronological age was (61.1±10.4) years, the cardiovascular age was (69.5±10.8) years. There were 31 775 patients in the high Age-Gap group and 15 474 in the low Age-Gap group. Cardiovascular age was positively correlated with chronological age (r=0.87, P<0.000 1). The follow-up duration was 39.6 (24.0, 59.6) months. The incidence of MACCE was significantly higher in the high Age-Gap group than that in the low Age-Gap group (12.99% (4 127/31 775) vs. 7.86% (1 216/15 474), P<0.000 1). After adjustment for age, sex, smoking status, and other confounders, Cox regression analysis showed that patients in the high Age-Gap group had a significantly increased risk of MACCE compared with those in the low Age-Gap group (HR=1.47, 95%CI 1.37-1.58, P<0.000 1). Higher risks were also observed for cardiac death (HR=2.72, 95%CI 2.36-3.15, P<0.000 1), myocardial infarction (HR=1.77, 95%CI 1.46-2.14, P<0.000 1), stroke (HR=1.24, 95%CI 1.05-1.46, P=0.010 9), and all-cause mortality (HR=2.01, 95%CI 1.81-2.23, P<0.000 1). Restricted cubic spline analyses demonstrated a nonlinear association between Age-Gap and the risks of MACCE, cardiac death and all-cause mortality, with a marked increase in risk as Age-Gap increased (all P-nonlinear<0.000 1; all P-overall<0.000 1). Conclusions: The application of large language model to predict cardiovascular age in ACS patients is feasible, and the Age-Gap exhibits a significant correlation with the risk of MACCE and mortality in this patient population. The cardiovascular age predicted by large language model offers a novel perspective for individualized risk assessment in ACS patients. 目的: 探讨基于大语言模型的心血管年龄预测方法在急性冠脉综合征(ACS)患者预后评估中的应用价值。 方法: 本研究是一项回顾性队列研究,纳入2015年11月至2023年5月于解放军北部战区总医院心血管内科住院并接受经皮冠状动脉介入治疗的ACS患者47 249例。通过北部战区总医院心血管急危重症智能大模型结合患者的人口学特征、既往病史及实验室检验数据,预测患者的心血管年龄,进一步计算心血管年龄与实际年龄的差值(Age-Gap)。将患者分为高Age-Gap组(Age-Gap≥8岁)和低Age-Gap组(Age-Gap<8岁)。主要终点为主要不良心脑血管事件(MACCE),包括心原性死亡、心肌梗死、卒中和靶血管血运重建,次要终点为MACCE的各个组分及全因死亡。采用皮尔逊相关分析评估心血管年龄与实际年龄的相关性。使用Cox比例风险回归模型评估Age-Gap对ACS患者终点事件发生风险的影响,并应用限制性立方样条法分析Age-Gap与各终点事件之间的非线性关系。 结果: 患者的实际年龄为(61.1±10.4)岁,心血管年龄为(69.5±10.8)岁。高Age-Gap组31 775例,低Age-Gap组15 474例。心血管年龄与实际年龄呈正相关(r=0.87,P<0.000 1)。随访时间为39.6(24.0,59.6)个月。高Age-Gap组患者的MACCE发生率高于低Age-Gap组[12.99%(4 127/31 775)比7.86%(1 216/15 474),P<0.000 1]。Cox比例风险回归分析结果显示,校正年龄、性别、吸烟等因素后,与低Age-Gap患者相比,高Age-Gap患者发生MACCE风险更高(HR=1.47,95%CI 1.37~1.58,P<0.000 1);心原性死亡(HR=2.72,95%CI 2.36~3.15,P<0.000 1)、心肌梗死(HR=1.77,95%CI 1.46~2.14,P<0.000 1)、卒中(HR=1.24,95%CI 1.05~1.46,P=0.010 9)及全因死亡(HR=2.01,95%CI 1.81~2.23,P<0.000 1)的发生风险均更高。限制性立方样条分析结果表明,Age-Gap与MACCE、心原性死亡及全因死亡风险存在非线性关系,随着Age-Gap增加患者发生上述事件的风险明显升高(P-nonlinear均<0.000 1,P-overall均<0.000 1)。 结论: 采用大语言模型预测ACS患者的心血管年龄技术可行,所得的Age-Gap与ACS患者的MACCE及全因死亡风险显著相关,为ACS患者的个体化风险评估提供了一个新的视角。.
引用
- Liu, Duan, Qi, et al. [Cardiovascular age prediction based on large language models and prognostic value analysis in acute coronary syndrome patients]. Zhonghua Xin Xue Guan Bing Za Zhi. 2026. PMID: 41688178. doi:10.3760/cma.j.cn112148-20251127-00831
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。